KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $189.2 million.

  • Vir Biotechnology's Total Non-Current Liabilities fell 1571.96% to $189.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.2 million, marking a year-over-year decrease of 1571.96%. This contributed to the annual value of $224.4 million for FY2024, which is 2591.46% down from last year.
  • Vir Biotechnology's Total Non-Current Liabilities amounted to $189.2 million in Q3 2025, which was down 1571.96% from $211.4 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Total Non-Current Liabilities ranged from a high of $867.2 million in Q1 2022 and a low of $189.2 million during Q3 2025
  • Its 5-year average for Total Non-Current Liabilities is $394.3 million, with a median of $313.2 million in 2021.
  • Per our database at Business Quant, Vir Biotechnology's Total Non-Current Liabilities surged by 43011.63% in 2021 and then plummeted by 6738.33% in 2024.
  • Vir Biotechnology's Total Non-Current Liabilities (Quarter) stood at $499.6 million in 2021, then surged by 39.95% to $699.2 million in 2022, then crashed by 56.68% to $302.9 million in 2023, then fell by 25.91% to $224.4 million in 2024, then dropped by 15.69% to $189.2 million in 2025.
  • Its Total Non-Current Liabilities was $189.2 million in Q3 2025, compared to $211.4 million in Q2 2025 and $240.3 million in Q1 2025.